This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Sk Chemicals Co., Ltd.. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gyeonggi-do, KR (2014)
- Suwon-si, KR (2013 - 2015)
Company Filing History:
Years Active: 2013-2015
Title: Yong Youn Hwang: Innovator in Transdermal Drug Delivery
Introduction
Yong Youn Hwang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of transdermal drug delivery, holding a total of 3 patents. His work focuses on improving the stability and effectiveness of drug compositions for transdermal administration.
Latest Patents
Hwang's latest patents include a transdermal composition comprising tolterodine, which features improved storage stability. This innovative composition incorporates an antioxidant to stabilize tolterodine, allowing for extended storage periods. Another significant patent is a composition designed for enhanced skin penetration of tolterodine, which includes lidocaine or a pharmaceutically acceptable salt. This formulation aims to improve the skin penetration of tolterodine, paving the way for successful commercial applications in transdermal preparations.
Career Highlights
Throughout his career, Yong Youn Hwang has worked with reputable organizations, including Sk Chemicals Co., Ltd. and Ewha University-Industry Collaboration Foundation. His experience in these institutions has contributed to his expertise in drug formulation and delivery systems.
Collaborations
Hwang has collaborated with notable colleagues such as Won Jae Choi and Yeo-Jin Park, further enhancing his research and development efforts in the pharmaceutical field.
Conclusion
Yong Youn Hwang's innovative work in transdermal drug delivery exemplifies his commitment to advancing medical science. His patents reflect a dedication to improving patient care through effective drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
